François Pattou is Professor of General Surgery in the Faculty of Medicine at Lille University, France, and Head of the Department of General and Endocrine at Lille University Hospital.
He leads a research group at the University of Lille, INSERM U1190, devoted to the clinical development of biotherapies for treating diabetes, and is a founding member of the LABEX European Genomic Institute for Diabetes (EGID). Professor Pattou’s research is devoted to the surgical treatment of endocrine and metabolic diseases and focuses on cell therapy for type 1 diabetes and metabolic surgery for type 2 diabetes. He is also the principal investigator of several ongoing clinical trials of islet cell transplantation and metabolic surgery. He has authored more than 250 papers in peer-reviewed journals.
The recipient of numerous research grants from national and international institutions (European Commission, Innovative Medicine Initiative, Agence Nationale de la Recherche, Juvenile Diabetes Research Foundation, Foundation Francophone pour le recherche sur le diabète), Professor Pattou has been awarded several prizes (National Academy of Medicine, Rachmine Levine scientific achievement award, Matmut award). He is a member of the European Surgical Association and is President of the Association Francophone de Chirurgie Endocrinienne. He is regularly invited to give lectures at international conferences and teaching courses such as the EASD e-Learning programme.
Duality of Interest: Professor Pattou has received speaker’s fees/honoraria from Novo Nordisk, Medtronic and Ehthicon. He has also received payments for membership of boards/advisory panels from Novo Nordisk, Medtronic and Ehthicon.
Date: Summer 2023